Genetic marker, predictor of early relapse in pediatric ALL uncovered

Researchers recently discovered that by testing the level of NER (nucleotide excision repair) gene expression, pediatric oncologists can determine the likelihood of early relapse (less than three years) in their acute lymphoblastic leukemia (ALL) patients.

Leave a Reply

Your email address will not be published.